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Lithium is known to potentiate the ability of pilocarpine to induce status epilepticus in rats. The goal of this study was to determine whether
lithium could potentiate pilocarpine-induced seizures in developing animals. Behavioral, electroencephalographic (EEG), and histopathological
changes induced by systemic administration of lithium (3 meqykg) followed 20 h later by pilocarpine 0, 10, 30, 60 mgZkg) were studied in
3-30-day-old rats. Lithium followed by pilocarpine 00 and 60 mgy'kg) induced hyperactivity, tremor, loss of postural control and scratching but
no electrographic seizures in 3-8-day-old rats. In the 7-IO-day-old animals pretreatment with lithium and pilocarpine 60 mg/kg induced status
epilepticus with sustained myoclonus and continuous bilateral synchronous spike and sharp wave, but doses of pilocarpine lower than 60 mgy'kg
had no effect. The susceptibility to lithium-pilocarpine-induced status epilepticus increased markedly during the third postnatal week of life.
During this time period, rats treated with lithium (3 meqjkg) plus pilocarpine 10 mgZkgexhibited behavioral and EEG manifestations of status
epilepticus. The same combination of lithium and pilocarpine failed to induce status epilepticus either before or after the third week of life.
Histopathological analysis of the brains of the animals used in these studies failed to demonstrate the widespread damage reported in adult rats
that have undergone lithium-pilocarpine-induced status epilepticus.
INTRODUCTION
High-dose treatment with pilocarpine, a cholinergic
agonist, results in sustained seizures and status epilep-
ticus accompanied by widespread brain damage in adult
rats20,21. The susceptibility of rats to pilocarpine-in-
duced seizures and status epilepticus is age-depen-
dent" with an adult pattern of behavioral and electro-
graphic seizures encountered in 15-21-day-old rats,
while younger animals do not exhibit overt motor
seizures. Both lethality and potency of pilocarpine an':
increased during the third week of life relative to older
and younger animals".
In adult rats the epileptogenic effect of pilocarpine
and other muscarinic cholinergic agonist is markedly
potentiated by lithium 8,10,11,14. Pretreatment with
lithium (3 meqykg) 24 h before pilocarpine (30 rngykg)
results in EEG and behavioral changes similar to those
seen with high dose pilocarpine. We studied the
epileptogenic effect of lithium-pilocarpine during on-
togenesis in rats in an attempt to determine whether
lithium potentiates low doses of pilocarpine in develop-
ing animals. In addition we sought to ascertain whether
younger animals were more susceptible to lithium-
pilocarpine-induced status epilepticus.
MATERIALS AND METHODS
Animals
Six timed-pregnancy Sprague-Dawley rats were obtained from
Zivic-Miller, (Zelionple, PA) at the 17th or 18th gestational day. The
pregnant animals were housed under a 12-h light/dark cycle, and
fed ad libitum. Delivery times were monitored and were accurate to
within 12 h. The day of birth was considered day zero. The pups
were kept with the mothers, and litters were culled to 12 pups. The
groups of animals used in these studies were mixed such that each
group contained pups from several litters. The age groups studied
included animals of 3-6, 7-10, 11-14, 15-21 and 22-30 postnatal
days of age. These age ranges were chosen to reflect the stages of
development examined in other studies of the ontogeny of experi-
Correspondence: O.c. Snead lll, Childrens Hospital of Los Angeles, Department of Neurology, Box 82, 4650 Sunset Boulevard, Los Angeles, CA
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mental seizures in rats 3,6,18,22,23. Each pup was drug naive and
subjected to lithium-pilocarpine only once.
Drugs
Pilocarpine hydrochloride and lithium chloride were purchased
from Sigma (St. Louis, MO, USA), On the day of the experiments
the drugs were freshly dissolved in saline (pilocarpine) or water
(lithium chloride). Lithium (3 meqykg) was administered intraperi-
toneally (i.p.) 20 h before pilocarpine which was given subcutaneous-
lly (s.c.), The volume of injection for both lithium and pilocarpine
was 0.1 ml/lO·g body weight. Pilocarpine was administered in doses
of 3, 10, 30 or 60 mgykg in order to determine the minimal dose
required to induce continuous electrographic and behavioral seizures.
There were six animals in each age group for each dose of pilo-
carpine used.
Surgery and recordings
Animals were anesthetized with halothane and placed in a
neonatal rat stereotaxic frame!", Two frontal and two posteroparietal
tungsten electrodes were implanted. Depth recordings were obtained
from bipolar twist concentric enamel stainless steel electrodes (tip
diameter 100 ILm, vertical interelectrode distance 0.5 mrn) placed in
the dorsal hippocampus and the nucleus accumbens. The stereotaxic
coordinates for these stuctures were derived for each age group from
the atlas of Sherwood and Timiras!", The technique allows for EEG
recording from freely moving animals, via long, flexible wires'",
The surgery was well tolerated. All animals recovered with a
normal righting and placing reflex within 2 h of cessation of
halothane. 2 h after recovery the pups were treated with lithium
chloride, observed for 1 h and returned to the mothers. 20 h later the
pups were removed from the litters, baseline EEG recordings made
for 30 min, and pilocarpine administered. EEG recordings were
made continuously with the animals unrestrained and behavior ob-
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served for periods ranging from 4 to 6 h following the s.c. administra-
tion of pilocarpine.
Histopathological analysis
Animals who survived seizures induced by the lithium-pilocar-
pine combination were sacrified by decapitation 3 days after the
administration of pilocarpine. This was chosen as an arbitrary time
period to allow full recovery from the seizures. The brains were
processed for pathological examination by light microscopy. 20 ILm
coronal frozen sections were stained with hematoxyllin and eosin and
examined microscopically to ascertain the presence of brain lesions
related to the seizures.
RESULTS
EEG
The results of these experiments are summarized in
Table I. In all groups of animals treated with lithium,
the baseline EEG was normal for age (Figs. 1-5).
3-6 days (n = 12; Fig 1). Pilocarpine, 30 and 60
mgykg, failed to induce seizure discharges on EEG.
There were no EEG changes that correlated with the
behavioral abnormalities noted above in this age group.
7-10 days (n = 12; Fig 2). Pilocarpine, 30 mg Zkg
(n = 6) failed to induce cortical or subcortical seizures;
60 mgykg (n = 4) induced simultaneous cortical and
subcortical seizures in all animals with a mean latency
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Fig. 1. Serial EEG recordings from a 3 day-old rat which received 60 mgykg pilocarpine 20 h after lithium 3 meqykg. a: baseline recording 20 h
following lithium, but prior to pilocarpine administration. b-f: EEG recorded from cortical and hippocampal electrodes 30-300 min after
pilocarpine 60 rngz'kg. The recordings show predominant movement artifact, a few isolated spikes and no electrographic seizure activity. R, right;
L, left; F, frontal; P, parietal; HPC, hippocampus. Horizontal scale 2 s, vertical 100 ILV.
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of 53.9 ± 11.6 min. Status epilepticus was observed in 3
animals at a dose of 60 mg Zkg with a mean latency of
73.2 ± 12.3 min. Pilocarpine-induced seizures in this
age group were characterized electrographically by the
occurrence of generalized synchronous polyspikes for
5-10 s associated with scratching and tonic extension
of hind limbs and tail. Status epilepticus was character-
ized by the occurrence of continuous generalized syn-
chronuous polyspikes and sharp waves associated with
forelimb clonus and loss of postural control. After 2-3
h the EEG returned to baseline.
11-14 days (n = 18; Fig. 3). Pilocarpine, 10 mgykg
(n = 6) failed to induce cortical or subcortical seizures;
30 mgykg dose induced electrographic seizures and
status epilepticus in all animals with a mean latency of
20.1 ±2.5 min to seizure and 44.1 ± 14.0 min to status
epilepticus; 60 mgykg induced electrical seizure activ-
ity recorded on EEG and status epilepticus in all
animals with a mean latency of 10.6 ± 2.7 min to seizure
and 24.1 ± 5.1 to status epilepticus. EEG changes and
status epilepticus were similar to those exhibited in the
7-1O-day-old group of animals. The EEG was abnor-
mal 6 h after cessation of the lithium-pilocarpine-in-
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duced status epilepticus and showed bilateral syn-
chronous generalized spikes and sharp waves which
were of larger amplitude than those seen after seizure
in the 7-1O-day-old group.
15-21 days (n = 24; Fig. 4). Pilocarpine, 3 mgy'kg
(n = 6) failed to induce cortical or subcortical seizures;
10 mgykg (n = 6) induced seizures and status epilepti-
cus in four animals with a mean latency of 40.8 ± 27.3
min to seizure and 44.8 ± 31.0 min to status epilepti-
cus. The EEG was abnormal 5 h after pilocarpine
injection, showing generalized synchronous spike and
wave at a frequency of 1 Hz. Both 30 and 60 mgykg
resulted in status epilepticus and death in all animals
tested (n = 12).
22-30 days (n = 18; Fig. 5). Pilocarpine, 10 mgy'kg
(n = 6) failed to induce cortical or subcortical seizures;
30 rngykg induced electrographic seizures and status
epilepticus in all animals tested with a mean latency of
32.5 ± 11.9 min to seizure and 43.3 ± 8.6 min to onset
of status epilepticus. Simultaneous cortical and subcor-
tical recordings obtained in two animals showed that
the pilocarpine-induced electrical seizure activity ap-
peared to originate in the nucleus accumbens-ventral
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Fig. 2. Serial EEG recordings in a 9-day-old rat which recieved pilocarpine 60 mg/kg 20 h after lithium 3 meqykg. a: baseline recording 20 h
following lithium, but prior to pilocarpine administration. b: 30 min following60 mgZkg pilocarpine; the EEG is unchanged from baseline. c: 60
min after pilocarpine injection; electrocorticographic and hippocampal recordings demonstrate bilateral polyspikes and sharp waves. Behaviorally
these were accompanied by forelimb clonus and loss of postural control. d: 120 min after pilocarpine; the seizures described above continue. e-f:
180-300 min after pilocarpine administration; the seizures have ceased and the EEG returned to baseline. R, right; L, left; F, frontal; P, parietal;
HPC, hippocampus. Horizontal scale 2 s, vertical 200 fLV.
TABLE I
Percentage of immature rats showing status epilepticus after lithium-
pilocarpine
n = 6 for all age groups and all doses of pilocarpine. The dose of
pilocarpine was administered s.c, 20 h following lithium chloride 3
meqjkg i.p.; (-) indicates that a study at this dose of pilocarpine was
not done.
Pilocarpine dose Postnatal age(days)
(mg j kg) 3-6 7-10 11-14 15-21 22-30
3 0 0
10 0 0 67 0
30 0 0 100 100 100
60 0 67 100 100 100
pallidum with subsequent spread to the dorsal hip-
pocampus and cortex. The one animal in this age group
which survived the status epilepticus had an abnormal
EEG 6 h after pilocarpine administration with bilateral
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synchronous 1-2 Hz spike and wave and sharp wave
discharges. All animals in the group who received 60
mgy'kg pilocarpine developed status epilepticus and
died (n = 6).
Behavioral manifestation of seizures
Although these data were analyzed separately from
the EEG data, no animal showed behavioral manifesta-
tions of seizures or status epilepticus without concomi-
tant electrographic manifestations of seizure.
3-6 days. Pretreatment with lithium and pilocarpine
in doses of 30 (n = 6) and 60 mg/kg (n = 6) induced
hyperactivity, tremor and scratching movements. These
behaviors appeared immediately following the adminis-
tration of pilocarpine and lasted for 2-3 h. No behav-
ioral response was seen to pilocarpine in doses of 3 or
10 mgykg, nor did lithium alone produce any behav-
ioral changes.
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Fig. 3. Serial EEG recordings from an l l-day-old rat which received pilocarpine 60 mgjkg 20 h after lithium 3 meqjkg. a: baseline recording 20
h following lithium, but prior to pilocarpine administration. b: 18 min after pilocarpine adminsitration; the electrographic seizure begins in
hippocampus and cortex simultaneously. c: 30 min following pilocarpine administration; electrocorticographic and hippocampal recordings
demonstrate bilateral polyspikes and sharp waves. Behaviorally these were accompanied by forelimb clonus and loss of postural control. d: 60
min following pilocarpine administration; there is marked attenuation of voltages in recordings from cortical electrodes but continuous spike
wave discharges emanating from hippocampus. The animals showed hindlimb extensor tonus during this time. R, right; L, left; F, frontal; P,
parietal; HPC, hippocampus. Top scale, horizontal 2 s, vertical 200 p..V. Bottom scale, horizontal 2 s, vertical 400 p..V.
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Fig. 4. Serial EEG recordings made from cortical electrodes in a 19-day-old rat which received pilocarpine 10 mg/kg 20 h after lithium 3
meqz'kg. a: baseline recording 20 h following lithium, but prior to pilocarpine administration. b-c: 60 and 100 min following 10 mgZkg
pilocarpine ; the EEG is unchanged from baseline. d-f: 120-300 min after pilocarpine administration ; bilateral polyspikes and sharp waves began
and showed increasing amplitude over time. These were accompanied by forelimb clonus and loss of postural control. R, right; L, left; F, frontal;
P, parietal. Left scale, horizontal 2 s, vertical 100 IJ.V. Right scale, horizontal 2 s, vertical 400 IJ.V.
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Fig. '5. Serial EEG recordings from a 27·day-old rat which received pilocarpine 30 mgykg 20 h after lithium 3 meqz'kg. This animal was
implanted with bipolar electrodes in hippocampus and nucleus accumbens and monopolar electrodes in cortex. a: baseline recording 20 h
following lithium, but prior to pilocarpine administration. b: 30 min after pilocarpine administration; initial polyspikes were recorded from
bipolar electrodes in the nucleus accumbens. c: 60 min after pilocarpine administration; electrographic seizures were recorded from both cortex
and nucleus accumbens, but no seizures were observed at this time in the hippocampus. d-e: 120 and 155 min following pilocarpine
administration ; seizures now involve cortex, nucleus accumbens and hippocampus. L, left; F, frontal; P, parietal ; HPC, hippocampus; NA,
nucleus accumbens. Left scale, horizonta12 s, veltical200 p.V. Right scale, horizontal 2s, vertical 400 p.V.
7-10 days. Pilocarpine 30 mg z'kg (n = 6) induced
defecation, continuous scratching and body tremor, but
no behavioral seizures; 60 mg z'kg resulted in tonic
extension of hind limbs and tail, sustained clonic move-
ments of the forelimbs and loss of postural control in
four of the six animals tested. All animals who experi-
enced these seizures survived.
11-14 days. Pilocarpine 10 mgykg (n = 6), induced
defecation, salivation, body tremor and scratching in all
animals, but no behavioral seizure activity; 30 mgykg
induced seizures and status epilepticus in all animals
(n = 6). Status epilepticus was defined as sustained
orofacial automatisms, salivation, forelimb clonus, and
rearing and falling in all animals. All animals survived
the status epilepticus induced by 30 mgy'kg. Status
epilepticus was observed in all animals at 60 mgy'kg
(n = 6), but 4 animals died at this higher dose of
pilocarpine 2 h after administration of the drug.
15-21 days. Pilocarpine, 3 mg z'kg (n = 6) induced
no behavioral abnormalities; 10 mgykg (n = 6) induced
seizures and status epilepticus in 4 animals similar to
that seen in 11-14-day-old animals treated with 30
rngykg of pilocarpine, with all animals surviving. The
30 mg z'kg dose of pilocarpine induced status epilepti-
cus in all 15-21-day-old animals tested (n = 6). Two of
these animals died 1 h following administration of
pilocarpine; 60 mgykg pilocarpine resulted in status
epilepticus and death within 1 h of drug administration
in all animals (n = 6).
22-30 days. Pilocarpine 10 mgy'kg (n = 6) induced
defecation, salivation and tremor but no seizures; 30
mgykg induced status epilepticus in all animals. Three
animals died within 2 h following the injection of the
drug; 60 mgykg resulted in status epilepticus in all
animals with death in 5/6 animals within 2 h.
Pathology
Histopathologic examination was done on 24 ani-
mals ranging in age from 7 to 30 days. These animals
were those described above who experienced lithium-
pilocarpine seizures and survived. Light microscopic
examination of brain sections taken from these animals
failed to reveal any morphological alterations.
DISCUSSION
This study demonstrates that systemic injection of
low doses of pilocarpine can induce status epilepticus
in developing rats pretreated with lithium.
The cholinergic neuronal network is functional by
the end of the second week of life in rats. The concen-
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tration of acetylcholine rises to 29% of adult levels by
birth and attains adult levels by 4 weeks postpartum".
From 7 to 28 postnatal days of age the specific activity
of whole brain choline acetyltransferase increases from
8 to 83% of that found in adult brain", [3H]Quinuc-
lidinyl benzylate, a specific muscarinic agonist, reaches
adult levels in the hippocampus at an age of 12-14
days of life",
Experimental epileptogenic phenomena mediated by
cholinergic mechanisms also appear to be demonstra-
ble by the end of the second week of life. Focal spike
discharges induced by intracortical administration of
acetylcholine have been reported in 12-day-old rats'".
In addition, pilocarpine alone in a dose of 380 mg z'kg
induces behavioral and EEG manifestations of status
epilepticus in rats during the second week of life6• The
current study is in agreement with these published data
since it suggests that the mechanisms by which lithium
potentiates pilocarpine are also in place by the second
week of life. There was over a 12-fold potentiation of
the epileptogentic effects of pilocarpine by lithium
demonstrated in the developing animals which is simi-
lar to that published for adults rats".
The proconvulsant effect of lithium is specifically
limited to muscarinic cholinergic agonists". However,
the way in which lithium exerts this effect remains to
be identified. Possible mechanisms include stimulation
of acetylcholine synthesis and release!' or inhibition of
phosphoinositide hydrolysis-? and/or cyclic AMP pro-
duction in rat brain".
The susceptibility to lithium-pilocarpine-induced
status epilepticus is increased during the third week of
life since 15-21-day-old animals treated with pilo-
carpine 10 mg zkg exhibited status epilepticus while the
same dose of pilocarpine failed to induce status epilep-
ticus during the first two weeks of life or in animals
older than 21 days. An increased susceptibility to pilo-
carpine-" and other proconvulsant drugs l ,3,6 during a
similar time period has been reported previously al-
though some authors have not observed this develop-
mental window of increased susceptibility to seizure/".
One possible explanation for this phenomenon could
be related to the precocious development of the excita-
tory systems within limbic structures and the delayed
appearance of inhibitory mechanisms at this age". An
alternative explanation for the differential susceptibil-
ity of developing animals to pilocarpine after lithium
pretreatment may relate to changes in the blood-brain
barrier with development. This could be reflected by
age-dependent changes in the pharmacokinetics of pi-
locarpine and/or lithium following systemic adminis-
tration. Hence the developmental changes observed
could reflect differing brain concentrations of lithium
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and/or pilocarpine achieved in animals of different
ages.
Adults rats who survive lithium-pilocarpine-induced
status epilepticus have been reported to show
widespread brain lesions in the ventral forebrain area?
However, we failed to demonstrate any brain lesions in
developing animals that experienced lithium-pilocar-
pine-induced status epilepticus, The literature suggests
that immature rats are more resistant to the develop-
ment of seizure-induced brain damage than adult ani-
mals. For example, in the kainic acid model of limbic
seizures and status epilepticus no lesions are described
until 33-37 days of life'. Pilocarpine alone in rat pups
is reported to induce an attenuated pattern of damage
compared to that seen in adults. The damage in imma-
ture animals treated with high dose pilocarpine is
limited to shrinkage of cells and loss of neurons in
hippocampus, amygdala, olfactory cortex, neocortex
and certain thalamic nuclei". In a model of status
epilepticus induced by systemic injection of bicuculIine
in three species of young animals, Wasterlain et al.22
showed that severe status epilepticus produced no is-
chemic cell necrosis in the immature animals.
In conclusion, we have delineated an electrographic
and behavioral model of status epilepticus during the
first weeks of postnatal life in rats. This paradigm
promises to be a useful model for further investigation
of the genesis and propagation of seizures in develop-
ing brain.
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